GlassScriptPhysician profile
George W Ma
NPI 1528178332
$706.39
in general payments reported to CMS, 2019-2025
14 companies · $25.80 in 2025
The $25.80 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $91.27 · 2021: $29.09 · 2023: $99.05 · 2025: $25.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.94 | 2019-2023 | Jardiance |
| Radius Health, INC. | $152.58 | 2019 | |
| Novo Nordisk INC | $78.04 | 2019 | |
| Amgen INC. | $55.73 | 2019-2025 | Repatha |
| Glaxosmithkline, LLC. | $37.23 | 2019-2023 | Arexvy, Shingrix |
| Amarin Pharma, INC. | $34.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.90 | 2020 | |
| Redhill Biopharma INC. | $19.98 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.98 | 2020 | |
| Scilex Pharmaceuticals INC. | $17.55 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2023 | |
| Allergan, INC. | $13.73 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.73 | 2019 | |
| Gilead Sciences, INC. | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.